This paper is in the following e-collection/theme issue:

Clinical Information and Decision Making (1916) mHealth in a Clinical Setting (744) Methods and Instruments in Medical Informatics (189) Advanced Data Analytics in eHealth (209) Machine Learning (2077) Network biology (3)

Published on in Vol 27 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65563, first published .
Risk Stratification in Immunoglobulin A Nephropathy Using Network Biomarkers: Development and Validation Study

Risk Stratification in Immunoglobulin A Nephropathy Using Network Biomarkers: Development and Validation Study

Risk Stratification in Immunoglobulin A Nephropathy Using Network Biomarkers: Development and Validation Study

Authors of this article:

Jiaxing Tan1 Author Orcid Image ;   Rongxin Yang2 Author Orcid Image ;   Liyin Xiao2 Author Orcid Image ;   Lingqiu Dong1 Author Orcid Image ;   Zhengxia Zhong3 Author Orcid Image ;   Ling Zhou4 Author Orcid Image ;   Wei Qin1 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Jiaxing Tan   1 * , MD, PhD ;   Rongxin Yang   2 * , BS ;   Liyin Xiao   2 , BS ;   Lingqiu Dong   1 , MD, PhD ;   Zhengxia Zhong   3 , MD, PhD ;   Ling Zhou   4 , MD ;   Wei Qin   1 , MD, PhD

1 Division of Nephrology, Department of Medicine, West China Hospital of Sichuan University, Chengdu, China

2 College of Computer Science, Sichuan University, Chengdu, China

3 Division of Nephrology, Department of Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China

4 Division of Nephrology, Zigong Third People's Hospital, Zigong, China

*these authors contributed equally

Corresponding Author:

  • Wei Qin, MD, PhD
  • Division of Nephrology, Department of Medicine
  • West China Hospital of Sichuan University
  • No 37 Guoxue Alley, Wuhou District
  • Chengdu 610041
  • China
  • Phone: 86 18980602119
  • Email: qinweihx@scu.edu.cn